82 related articles for article (PubMed ID: 24828199)
21. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
22. Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.
Song S; Christova T; Perusini S; Alizadeh S; Bao RY; Miller BW; Hurren R; Jitkova Y; Gronda M; Isaac M; Joseph B; Subramaniam R; Aman A; Chau A; Hogge DE; Weir SJ; Kasper J; Schimmer AD; Al-awar R; Wrana JL; Attisano L
Cancer Res; 2011 Dec; 71(24):7628-39. PubMed ID: 22009536
[TBL] [Abstract][Full Text] [Related]
23. Gliotoxin Inhibits Proliferation and Induces Apoptosis in Colorectal Cancer Cells.
Chen J; Wang C; Lan W; Huang C; Lin M; Wang Z; Liang W; Iwamoto A; Yang X; Liu H
Mar Drugs; 2015 Oct; 13(10):6259-73. PubMed ID: 26445050
[TBL] [Abstract][Full Text] [Related]
24. Fucoidan inhibited 4T1 mouse breast cancer cell growth in vivo and in vitro via downregulation of Wnt/β-catenin signaling.
Xue M; Ge Y; Zhang J; Liu Y; Wang Q; Hou L; Zheng Z
Nutr Cancer; 2013; 65(3):460-8. PubMed ID: 23530646
[TBL] [Abstract][Full Text] [Related]
25. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
26. Role of CSN5/JAB1 in Wnt/β-catenin activation in colorectal cancer cells.
Schütz AK; Hennes T; Jumpertz S; Fuchs S; Bernhagen J
FEBS Lett; 2012 Jun; 586(11):1645-51. PubMed ID: 22668871
[TBL] [Abstract][Full Text] [Related]
27. Expression and the clinical significance of Wnt10a and Wnt10b in endometrial cancer are associated with the Wnt/β-catenin pathway.
Chen H; Wang Y; Xue F
Oncol Rep; 2013 Feb; 29(2):507-14. PubMed ID: 23135473
[TBL] [Abstract][Full Text] [Related]
28. Docosahexaenoic acid inhibited the Wnt/β-catenin pathway and suppressed breast cancer cells in vitro and in vivo.
Xue M; Wang Q; Zhao J; Dong L; Ge Y; Hou L; Liu Y; Zheng Z
J Nutr Biochem; 2014 Feb; 25(2):104-10. PubMed ID: 24290517
[TBL] [Abstract][Full Text] [Related]
29. A Novel Inhibitor Targets Both Wnt Signaling and ATM/p53 in Colorectal Cancer.
Cheng J; Dwyer M; Okolotowicz KJ; Mercola M; Cashman JR
Cancer Res; 2018 Sep; 78(17):5072-5083. PubMed ID: 30032112
[TBL] [Abstract][Full Text] [Related]
30. Novel synthetic antagonists of canonical Wnt signaling inhibit colorectal cancer cell growth.
Waaler J; Machon O; von Kries JP; Wilson SR; Lundenes E; Wedlich D; Gradl D; Paulsen JE; Machonova O; Dembinski JL; Dinh H; Krauss S
Cancer Res; 2011 Jan; 71(1):197-205. PubMed ID: 21199802
[TBL] [Abstract][Full Text] [Related]
31. 2-methoxy-1,4-naphthoquinone isolated from Impatiens balsamina in a screening program for activity to inhibit Wnt signaling.
Mori N; Toume K; Arai MA; Koyano T; Kowithayakorn T; Ishibashi M
J Nat Med; 2011 Jan; 65(1):234-6. PubMed ID: 20886301
[TBL] [Abstract][Full Text] [Related]
32. Synergistic effect of indomethacin and NGX6 on proliferation and invasion by human colorectal cancer cells through modulation of the Wnt/beta-catenin signaling pathway.
Guo Q; Wu M; Lian P; Liao M; Xiao Z; Wang X; Shen S
Mol Cell Biochem; 2009 Oct; 330(1-2):71-81. PubMed ID: 19353243
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of interferon-induced protein 2 (IFIT2) by Wnt/β-catenin signaling confers anti-apoptotic properties to colorectal cancer cells.
Ohsugi T; Yamaguchi K; Zhu C; Ikenoue T; Furukawa Y
Oncotarget; 2017 Nov; 8(59):100176-100186. PubMed ID: 29245969
[TBL] [Abstract][Full Text] [Related]
34. Expression and role of nuclear receptor coregulators in colorectal cancer.
Triki M; Lapierre M; Cavailles V; Mokdad-Gargouri R
World J Gastroenterol; 2017 Jul; 23(25):4480-4490. PubMed ID: 28740336
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxicity of naphthoquinones and their capacity to generate reactive oxygen species is quenched when conjugated with gold nanoparticles.
Srinivas P; Patra CR; Bhattacharya S; Mukhopadhyay D
Int J Nanomedicine; 2011; 6():2113-22. PubMed ID: 22114475
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological targets and molecular mechanisms of plumbagin to treat colorectal cancer: A systematic pharmacology study.
Liang Y; Zhou R; Liang X; Kong X; Yang B
Eur J Pharmacol; 2020 Aug; 881():173227. PubMed ID: 32505664
[TBL] [Abstract][Full Text] [Related]
37. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity.
Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H
Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247
[TBL] [Abstract][Full Text] [Related]
38. Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling.
Xue YL; Meng XQ; Ma LJ; Yuan Z
Oncol Lett; 2016 Aug; 12(2):1095-1100. PubMed ID: 27446400
[TBL] [Abstract][Full Text] [Related]
39. Plumbagin-Serum Albumin Interaction: Spectral, Electrochemical, Structure-Binding Analysis, Antiproliferative and Cell Signaling Aspects with Implications for Anticancer Therapy.
Chrastina A; Welsh J; Rondeau G; Abedinpour P; Borgström P; Baron VT
ChemMedChem; 2020 Jul; 15(14):1338-1347. PubMed ID: 32410390
[TBL] [Abstract][Full Text] [Related]
40. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.
He B; Reguart N; You L; Mazieres J; Xu Z; Lee AY; Mikami I; McCormick F; Jablons DM
Oncogene; 2005 Apr; 24(18):3054-8. PubMed ID: 15735684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
